Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.54 USD | -1.07% | +8.42% | -12.57% |
02:55pm | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Official Publications